BlackRock Inc. cut its stake in shares of Enzo Biochem, Inc. (NYSE:ENZ) by 1.3% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commiss
Enzo Biochem, Inc. (NYSE:ENZ) Q3 2020 Earnings Conference Call June 08, 2020 05:00 PM ET Company Participants Barry Weiner - President David Bench - Chief Finan
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 8) Biohaven Pharmaceutical...
Revenue of $17 million and EPS of ($0.21) due to COVID-19 impactAchieved major milestone with launch of comprehensive COVID-19 program for virus screening and antibody testing.

Enzo Biochem, Inc. to Host Earnings Call

07:00pm, Monday, 08'th Jun 2020
NEW YORK, NY / ACCESSWIRE / June 8, 2020 / Enzo Biochem, Inc. (NYSE:ENZ) will be discussing their earnings results in their 2020 Third Quarter Earnings call to be held on June 8, 2020 at 5:00 PM Easte

Earnings Scheduled For June 8, 2020

08:04am, Monday, 08'th Jun 2020
The biotech space saw a flurry of activity last week, with coronavirus-related news, conference presentations and IPOs. Negative clinical readouts led to some strong selling in...
NEW YORK, NY, June 03, 2020 -- Enzo Biochem, Inc.  (NYSE: ENZ) a leading biosciences and diagnostics company, today announced that it will release its third quarter 2020.
Enzo Biochem, Inc. (ENZ), a leading biosciences and diagnostics company, today announced that it is currently offering a SARS-CoV-2 IgG ELISA assay kit for serological detection of IgG antibodies aga
May 12, 2020 (Heraldkeepers) -- New York, May 12, 2020: The report covers detailed competitive outlook including the market share and company profiles of the...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE